Genzyme Corporation (Nasdaq: GENZ) said the FDA has informed the company of its opinion that Myozyme produced at the 160L ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE